Claude

The Full Story

Everest Industries spent five years telling investors it was transforming from an asbestos-roofing legacy business into a diversified building solutions provider. That story peaked in FY2021-FY2023, when debt-free operations and record Boards & Panels performance made the pivot credible. But the pivot stalled. Asbestos fibre inflation, a struggling steel buildings division, aggressive capex on a Mysore greenfield, and rising debt have driven the company from peak EPS of ₹36 in FY2021 to a loss-making position in FY2025 (EPS of -₹2.28) and deepening losses in the current year (TTM EPS of -₹29.55). The MD & CEO, Rajesh Joshi, resigned in June 2025 effective September 2025, leaving no announced successor. Management credibility has deteriorated significantly: every promise of margin improvement, capacity-led growth, and diversification away from roofing has been contradicted by the numbers.

The Narrative Arc

Everest Industries (founded 1934 as The Asbestos Cement Ltd.) has gone through three distinct narrative phases over the past decade.

Phase 1 – The REIMAGINE Peak (FY2019-FY2021). Under MD Manish Sanghi (who led from 2010 to 2020) and then Rajesh Joshi (appointed 2020), Everest paid off all debt, achieved its best margins (9% operating margin in FY2021), and began telling a story of three complementary businesses: Roofing (rural India, cash cow), Boards & Panels (urban India, high-growth), and Pre-Engineered Steel Buildings (industrial India, turnaround play). The "3S" mantra – Strength, Speed, Safety – was everywhere. The company became debt-free in FY2021 and management framed it as a structural turning point.

Phase 2 – The Capex Pivot (FY2022-FY2024). Management shifted the narrative from "debt-free and disciplined" to "capacity expansion for growth." In February 2023, the board approved ₹187 Cr for a new Boards & Panels plant at Chamarajanagar (near Mysore) and ₹125 Cr for a steel buildings plant in Andhra Pradesh. This was the biggest capex cycle in company history. The Mysore plant became operational in March 2024. But simultaneously, asbestos fibre costs surged due to the Russia-Ukraine war, roofing margins collapsed, and the PEB division struggled with low volumes. Interest costs went from ₹3 Cr in FY2022 to ₹24 Cr in FY2025 as debt returned. The Andhra Pradesh plant was delayed and is now pushed to FY2027.

Phase 3 – The Crisis (FY2025-present). The company reported its first annual loss in recent memory. TTM operating income is negative at -₹2 Cr. Q3 FY2026 saw a loss of ₹48 Cr pre-tax on declining revenues. Rajesh Joshi resigned in June 2025 (effective September 2025). The stock has fallen over 55% from its highs, now trading below book value at 0.92x P/B.

What Management Emphasized – and Then Stopped Emphasizing

Dropped narratives:

"Debt-free" was the crown jewel of FY2021-FY2022 communications. By FY2023, the company had taken on debt for capex and this phrase quietly disappeared. By FY2025, the debt-equity ratio had risen to 0.27 and interest coverage had turned negative.

"PEB turnaround" was heavily promoted in FY2022-FY2023 when the steel buildings division booked its largest orders and management spoke of "market leadership potential." By FY2024-FY2025, PEB volumes had collapsed, the Andhra Pradesh plant was delayed to FY2027, and the division became a drag on profitability. The FY2025 annual report barely mentions steel buildings performance.

Persistent narratives:

"REIMAGINE" has been the brand mantra since 2020 and persists in every annual report, though with diminishing conviction. By FY2025, it was joined by "Reinforce" and "Rise" – defensive language acknowledging that the foundation needs repair.

ESG and sustainability emphasis increased every year, likely as a hedge against the existential asbestos risk. Management increasingly highlights non-asbestos products, the Mysore plant's green credentials, and alternative fibre sourcing.

Newly appeared:

"Data centres" as a growth market for Boards & Panels appeared in FY2023-FY2024 but has not yet delivered visible revenue contribution.

Risk Evolution

What became more important: The Russia-Ukraine war elevated chrysotile fibre supply risk from zero to critical overnight in FY2022 and it has remained a persistent headache. Fibre cement board competition intensified as rivals expanded capacity (the market grew at 12-13% CAGR but new entrants drove price competition). Capex execution risk escalated as the company committed ₹312 Cr to two greenfield projects while profits were declining.

What is newly visible: Leadership stability became a top risk in FY2025 when the MD & CEO resigned with no successor announced. The company is now navigating its worst financial performance in a decade without a permanent leader.

The asbestos question: Management has consistently downplayed the risk of an asbestos ban in India, noting that chrysotile usage is "extremely low" and bound in a cement matrix. While India has not banned asbestos use (only mining), 70+ countries have banned it entirely. Everest has been investing in non-asbestos products (Evercool, fibre cement boards) but the roofing division – still the largest revenue contributor – remains fundamentally an asbestos-cement business. The risk discussion in annual reports has shifted from "no adverse effects" (FY2021) to "working in a structured manner to develop non-asbestos products" (FY2022-FY2024), signalling quiet preparation for a possible regulatory shift.

How They Handled Bad News

FY2022 – Margin compression from input costs. Management was relatively transparent: the business "faced significant challenges" as imported asbestos fibre costs increased "significantly due to the ongoing Russia-Ukraine War." They attributed roofing profit decline to external forces and highlighted that the company remained debt-free. This was honest but did not prepare investors for the multi-year cost headwind that followed.

FY2024 – Broad profitability decline. The annual report acknowledged "challenges" but buried the scale of deterioration in optimistic language. Operating profit margin fell from 2.1% to 0.75%, yet the chairman described it as a year of "expand, innovate, reimagine." The gap between rhetoric and results widened significantly here.

FY2025 – First loss year. The FY2025 annual report, titled "Reimagine. Reinforce. Rise," adopted defensive but carefully worded language about "a period of deliberate investment and corrections, where growth was driven by purpose and measured not only in numbers but also in the value we created across our ecosystem." This is euphemistic language for a year where the company lost money. There is no direct acknowledgment of the severity of the earnings collapse.

MD resignation (June 2025). Rajesh Joshi's departure was disclosed as being for "personal reasons" with no further explanation. The timing – during the worst financial performance in company history – is notable. No successor has been announced.

Guidance Track Record

Score: 2 out of 10. The only guidance that was met was the Mysore plant timeline (which actually came in slightly early). Every other significant commitment – maintaining zero debt, restoring roofing margins, sustaining the PEB turnaround, and building the AP plant – has been missed, some by a wide margin. The gap between the aspirational tone of annual reports and the deteriorating financials is the core credibility issue. Management has consistently framed setbacks as temporary while the trajectory has been structurally downward for four consecutive years.

What the Story Is Now

Everest Industries is in crisis mode. The three-part transformation story – roofing cash cow, boards growth engine, PEB turnaround – has collapsed on all fronts simultaneously.

What has been de-risked: The Mysore plant is operational and adds genuine capacity for the boards and panels business, which has the strongest structural tailwinds (FCB market growing at 12-13% CAGR). Non-asbestos product development continues. The company has physical assets (8 plants, 13,000+ dealer outlets) that have real value.

What still looks stretched: The idea that Everest can simultaneously grow its way out of a profitability crisis while servicing new debt and managing a leadership transition. The roofing business faces a structural ceiling (asbestos cement sheet market growing at only 1-2% CAGR). The PEB division has lost momentum with the AP plant delayed to FY2027. Interest coverage is negative.

What to believe: The Boards & Panels business has a genuine growth path, but it cannot single-handedly rescue the company while roofing and PEB are struggling. The stock at 0.92x book value is pricing in significant distress. A new MD appointment and a credible margin recovery plan would be the minimum requirements for a re-rating.

What to discount: Any management language about "deliberate investment" framing losses as strategic choices. The deterioration from ₹36 EPS to -₹30 TTM EPS over five years is not a plan; it is a compounding series of failures to execute in a difficult environment. The REIMAGINE brand positioning, now in its sixth year, has become disconnected from financial reality.